Parkinson’s disease: Belgian scientists make a discovery that paves the way for new treatments

A research team from UCLouvain has highlighted the function of the PARK7 enzyme, which seems to play a role in the development of Parkinson’s disease. This discovery opens the way to new treatments, “which would target the origin of this neurodegenerative disease rather than its symptoms”, announced Monday the establishment in a press release. Scientists from the Duve Institute (UCLouvain), led by Professor Guido Bommer, have discovered that the PARK7 enzyme prevents damage caused to cells during the metabolism of sugars by glycolysis, i.e. all of the reactions that make it possible to break down glucose for the purpose of producing energy.

However, the PARK7 enzyme is inactive in some patients with Parkinson’s disease. The researchers therefore assume that there is an explanation for the appearance of this very debilitating disease, the development of which is still unknown today.

Leave a Replay